This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Artery Disease (CAD)
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Postmarket surveillance in terms of the safety and efficacy of Sirolimus-eluting Coroflex ISAR Stent for the treatment of "real world" patients with de-novo and restenotic lesions after stand-alone angioplasty in coronary arteries

Provided treatments

  • Device: stenting with the Coroflex ISAR sirolimus-eluting stent

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02629575. The sponsor of the trial is B. Braun Melsungen AG and it is looking for 2877 volunteers for the current phase.
Official trial title:
Coroflex ISAR 2000 Postmarket Surveillance Non-Interventional Study